Loading...
XKRX
200130
Market cap265mUSD
Dec 05, Last price  
13,390.00KRW
1D
0.83%
1Q
-14.33%
Jan 2017
-27.82%
IPO
136.99%
Name

KolmarBNH Co Ltd

Chart & Performance

D1W1MN
XKRX:200130 chart
P/E
21.68
P/S
0.64
EPS
617.74
Div Yield, %
Shrs. gr., 5y
-0.31%
Rev. gr., 5y
7.00%
Revenues
615.64b
+6.23%
0236,186,775,021256,009,784,673337,569,054,611386,365,758,808438,905,517,930606,891,551,147593,080,731,909575,902,994,059579,551,538,020615,642,005,000
Net income
18.05b
-8.41%
-825,998,2201,130,065,27829,707,524,79145,771,715,84148,352,739,88554,484,240,35480,484,423,11069,866,436,18040,512,833,05019,709,709,71018,052,525,000
CFO
39.20b
-30.36%
-424,305,38717,309,961,70720,684,402,05253,319,627,66122,045,062,46478,203,594,15277,090,164,97171,939,580,0965,325,746,30156,282,493,36239,195,695,000
Dividend
Dec 27, 2023308 KRW/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Kolmar BNH Co., Ltd. engages in the research and development of cosmetics, health functional foods, and functional ingredients in South Korea and internationally. It also provides vitamins and minerals, weight control, sports/nutrition, intestinal health, and other products, as well as products for men/women. The company was formerly known as Sun Bio Tech and changed its name to Kolmar BNH Co., Ltd. in 2013. The company was founded in 2004 and is based in Sejong, South Korea. Kolmar BNH Co., Ltd. is a subsidiary of Kolmar Korea Holdings Co., Ltd.
IPO date
Jul 23, 2014
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT